UniProt ID | PRS6A_HUMAN | |
---|---|---|
UniProt AC | P17980 | |
Protein Name | 26S proteasome regulatory subunit 6A | |
Gene Name | PSMC3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 439 | |
Subcellular Localization | Cytoplasm . Nucleus . Colocalizes with TRIM5 in the cytoplasmic bodies. | |
Protein Description | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC3 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides.. | |
Protein Sequence | MNLLPNIESPVTRQEKMATVWDEAEQDGIGEEVLKMSTEEIIQRTRLLDSEIKIMKSEVLRVTHELQAMKDKIKENSEKIKVNKTLPYLVSNVIELLDVDPNDQEEDGANIDLDSQRKGKCAVIKTSTRQTYFLPVIGLVDAEKLKPGDLVGVNKDSYLILETLPTEYDSRVKAMEVDERPTEQYSDIGGLDKQIQELVEAIVLPMNHKEKFENLGIQPPKGVLMYGPPGTGKTLLARACAAQTKATFLKLAGPQLVQMFIGDGAKLVRDAFALAKEKAPSIIFIDELDAIGTKRFDSEKAGDREVQRTMLELLNQLDGFQPNTQVKVIAATNRVDILDPALLRSGRLDRKIEFPMPNEEARARIMQIHSRKMNVSPDVNYEELARCTDDFNGAQCKAVCVEAGMIALRRGATELTHEDYMEGILEVQAKKKANLQYYA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNLLPNIE -------CCCCCCCC | 7.81 | 20068231 | |
9 | Phosphorylation | NLLPNIESPVTRQEK CCCCCCCCCCCHHHH | 22.37 | 29255136 | |
12 | Phosphorylation | PNIESPVTRQEKMAT CCCCCCCCHHHHHHH | 29.98 | 29255136 | |
16 | Ubiquitination | SPVTRQEKMATVWDE CCCCHHHHHHHHHHH | 26.04 | 21890473 | |
19 | Phosphorylation | TRQEKMATVWDEAEQ CHHHHHHHHHHHHHH | 20.73 | 21601212 | |
35 | Ubiquitination | GIGEEVLKMSTEEII CCCHHHHHCCHHHHH | 35.66 | 21890473 | |
36 | Sulfoxidation | IGEEVLKMSTEEIIQ CCHHHHHCCHHHHHH | 5.39 | 30846556 | |
37 | Phosphorylation | GEEVLKMSTEEIIQR CHHHHHCCHHHHHHH | 30.95 | 21815630 | |
38 | Phosphorylation | EEVLKMSTEEIIQRT HHHHHCCHHHHHHHH | 33.85 | 29255136 | |
45 | Phosphorylation | TEEIIQRTRLLDSEI HHHHHHHHHHHHHHH | 14.86 | 28787133 | |
50 | Phosphorylation | QRTRLLDSEIKIMKS HHHHHHHHHHHHCHH | 40.99 | 21815630 | |
53 | Succinylation | RLLDSEIKIMKSEVL HHHHHHHHHCHHHHH | 32.47 | 23954790 | |
53 | Ubiquitination | RLLDSEIKIMKSEVL HHHHHHHHHCHHHHH | 32.47 | 21890473 | |
53 | 2-Hydroxyisobutyrylation | RLLDSEIKIMKSEVL HHHHHHHHHCHHHHH | 32.47 | - | |
53 | Acetylation | RLLDSEIKIMKSEVL HHHHHHHHHCHHHHH | 32.47 | 25038526 | |
56 | Acetylation | DSEIKIMKSEVLRVT HHHHHHCHHHHHHHH | 47.11 | 25953088 | |
56 | Ubiquitination | DSEIKIMKSEVLRVT HHHHHHCHHHHHHHH | 47.11 | 21890473 | |
61 | Methylation | IMKSEVLRVTHELQA HCHHHHHHHHHHHHH | 36.14 | 115492871 | |
69 | Sulfoxidation | VTHELQAMKDKIKEN HHHHHHHHHHHHHHC | 3.58 | 30846556 | |
70 | Acetylation | THELQAMKDKIKENS HHHHHHHHHHHHHCH | 59.91 | 25953088 | |
70 | Ubiquitination | THELQAMKDKIKENS HHHHHHHHHHHHHCH | 59.91 | 21890473 | |
70 | 2-Hydroxyisobutyrylation | THELQAMKDKIKENS HHHHHHHHHHHHHCH | 59.91 | - | |
72 | Ubiquitination | ELQAMKDKIKENSEK HHHHHHHHHHHCHHH | 50.59 | - | |
74 | Ubiquitination | QAMKDKIKENSEKIK HHHHHHHHHCHHHHC | 57.49 | - | |
79 | Acetylation | KIKENSEKIKVNKTL HHHHCHHHHCCCCHH | 47.88 | 25953088 | |
79 | Ubiquitination | KIKENSEKIKVNKTL HHHHCHHHHCCCCHH | 47.88 | - | |
84 | Ubiquitination | SEKIKVNKTLPYLVS HHHHCCCCHHHHHHH | 55.19 | - | |
118 | Ubiquitination | IDLDSQRKGKCAVIK CCCCCCCCCCEEEEE | 55.90 | - | |
125 | Ubiquitination | KGKCAVIKTSTRQTY CCCEEEEECCCCCEE | 29.80 | - | |
125 | Acetylation | KGKCAVIKTSTRQTY CCCEEEEECCCCCEE | 29.80 | 25953088 | |
131 | Phosphorylation | IKTSTRQTYFLPVIG EECCCCCEEEEEEEE | 16.98 | - | |
132 | Phosphorylation | KTSTRQTYFLPVIGL ECCCCCEEEEEEEEE | 8.52 | 20090780 | |
144 | Ubiquitination | IGLVDAEKLKPGDLV EEEEEHHHCCCCCEE | 64.63 | 21890473 | |
146 | Ubiquitination | LVDAEKLKPGDLVGV EEEHHHCCCCCEECC | 59.01 | 21890473 | |
155 | Ubiquitination | GDLVGVNKDSYLILE CCEECCCCCCEEEEE | 45.72 | 21890473 | |
163 | Phosphorylation | DSYLILETLPTEYDS CCEEEEECCCCCCHH | 34.29 | - | |
173 | Ubiquitination | TEYDSRVKAMEVDER CCCHHHCEEEECCCC | 40.69 | 21890473 | |
175 | Sulfoxidation | YDSRVKAMEVDERPT CHHHCEEEECCCCCC | 4.23 | 30846556 | |
182 | Phosphorylation | MEVDERPTEQYSDIG EECCCCCCHHHCCCC | 41.77 | 28796482 | |
185 | Phosphorylation | DERPTEQYSDIGGLD CCCCCHHHCCCCCHH | 11.32 | 28796482 | |
186 | Phosphorylation | ERPTEQYSDIGGLDK CCCCHHHCCCCCHHH | 23.57 | 28796482 | |
193 | Ubiquitination | SDIGGLDKQIQELVE CCCCCHHHHHHHHHH | 55.11 | - | |
206 | Sulfoxidation | VEAIVLPMNHKEKFE HHHHHCCCCCHHHHH | 7.79 | 30846556 | |
209 | Ubiquitination | IVLPMNHKEKFENLG HHCCCCCHHHHHHCC | 58.56 | 21890473 | |
211 | Acetylation | LPMNHKEKFENLGIQ CCCCCHHHHHHCCCC | 63.88 | 23954790 | |
211 | Ubiquitination | LPMNHKEKFENLGIQ CCCCCHHHHHHCCCC | 63.88 | 21890473 | |
221 | Ubiquitination | NLGIQPPKGVLMYGP HCCCCCCCCEEEECC | 69.23 | - | |
225 | Sulfoxidation | QPPKGVLMYGPPGTG CCCCCEEEECCCCCC | 3.19 | 30846556 | |
226 | Phosphorylation | PPKGVLMYGPPGTGK CCCCEEEECCCCCCH | 23.48 | 23917254 | |
231 | Phosphorylation | LMYGPPGTGKTLLAR EEECCCCCCHHHHHH | 41.08 | 20068231 | |
233 | Ubiquitination | YGPPGTGKTLLARAC ECCCCCCHHHHHHHH | 35.52 | 21890473 | |
245 | Ubiquitination | RACAAQTKATFLKLA HHHHHHCHHHHHHHH | 33.09 | 21890473 | |
245 | Malonylation | RACAAQTKATFLKLA HHHHHHCHHHHHHHH | 33.09 | 26320211 | |
245 | 2-Hydroxyisobutyrylation | RACAAQTKATFLKLA HHHHHHCHHHHHHHH | 33.09 | - | |
245 | Acetylation | RACAAQTKATFLKLA HHHHHHCHHHHHHHH | 33.09 | 26051181 | |
250 | Ubiquitination | QTKATFLKLAGPQLV HCHHHHHHHHCHHHH | 31.90 | 21890473 | |
259 | Sulfoxidation | AGPQLVQMFIGDGAK HCHHHHHHHHCCHHH | 1.74 | 21406390 | |
266 | Ubiquitination | MFIGDGAKLVRDAFA HHHCCHHHHHHHHHH | 53.71 | 21890473 | |
276 | Succinylation | RDAFALAKEKAPSII HHHHHHHHCCCCEEE | 61.67 | 23954790 | |
276 | Ubiquitination | RDAFALAKEKAPSII HHHHHHHHCCCCEEE | 61.67 | - | |
278 | Ubiquitination | AFALAKEKAPSIIFI HHHHHHCCCCEEEEE | 65.96 | 21890473 | |
278 | 2-Hydroxyisobutyrylation | AFALAKEKAPSIIFI HHHHHHCCCCEEEEE | 65.96 | - | |
294 | 2-Hydroxyisobutyrylation | ELDAIGTKRFDSEKA CCCCCCCCCCCCCCC | 45.94 | - | |
294 | Ubiquitination | ELDAIGTKRFDSEKA CCCCCCCCCCCCCCC | 45.94 | 21890473 | |
300 | Acetylation | TKRFDSEKAGDREVQ CCCCCCCCCCCHHHH | 62.72 | 25953088 | |
300 | Ubiquitination | TKRFDSEKAGDREVQ CCCCCCCCCCCHHHH | 62.72 | 21890473 | |
310 | Sulfoxidation | DREVQRTMLELLNQL CHHHHHHHHHHHHHC | 2.74 | 28183972 | |
327 | Ubiquitination | FQPNTQVKVIAATNR CCCCCEEEEEEECCC | 20.36 | 21890473 | |
332 | Phosphorylation | QVKVIAATNRVDILD EEEEEEECCCCCCCC | 17.97 | 20068231 | |
345 | Phosphorylation | LDPALLRSGRLDRKI CCHHHHHCCCCCCEE | 28.38 | - | |
351 | Ubiquitination | RSGRLDRKIEFPMPN HCCCCCCEEECCCCC | 46.37 | - | |
356 | Sulfoxidation | DRKIEFPMPNEEARA CCEEECCCCCHHHHH | 7.27 | 21406390 | |
370 | Phosphorylation | ARIMQIHSRKMNVSP HHHHHHHHCCCCCCC | 34.91 | 21406692 | |
372 | Ubiquitination | IMQIHSRKMNVSPDV HHHHHHCCCCCCCCC | 37.53 | 21890473 | |
373 | Sulfoxidation | MQIHSRKMNVSPDVN HHHHHCCCCCCCCCC | 6.10 | 30846556 | |
376 | Phosphorylation | HSRKMNVSPDVNYEE HHCCCCCCCCCCHHH | 15.46 | 25159151 | |
381 | Phosphorylation | NVSPDVNYEELARCT CCCCCCCHHHHHHCC | 15.61 | 21406692 | |
388 | Phosphorylation | YEELARCTDDFNGAQ HHHHHHCCCCCCCCC | 32.81 | 21406692 | |
397 | Ubiquitination | DFNGAQCKAVCVEAG CCCCCCCEEEHHHHH | 31.60 | - | |
400 | Glutathionylation | GAQCKAVCVEAGMIA CCCCEEEHHHHHHHH | 2.46 | 22555962 | |
405 | Sulfoxidation | AVCVEAGMIALRRGA EEHHHHHHHHHHCCC | 1.77 | 21406390 | |
420 | Phosphorylation | TELTHEDYMEGILEV CCCCHHHHHHHHHHH | 8.29 | - | |
421 | Sulfoxidation | ELTHEDYMEGILEVQ CCCHHHHHHHHHHHH | 6.18 | 30846556 | |
431 | Ubiquitination | ILEVQAKKKANLQYY HHHHHHHHHCCCCCC | 61.20 | - | |
432 | Ubiquitination | LEVQAKKKANLQYYA HHHHHHHHCCCCCCC | 41.63 | - | |
437 | Phosphorylation | KKKANLQYYA----- HHHCCCCCCC----- | 12.43 | 29496907 | |
438 | Phosphorylation | KKANLQYYA------ HHCCCCCCC------ | 7.90 | 29496907 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRS6A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRS6A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRS6A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-9, AND MASS SPECTROMETRY. | |
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex."; Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.; Biochemistry 46:3553-3565(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, ACETYLATION AT MET-1,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-9, AND MASS SPECTROMETRY. | |
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex."; Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.; Biochemistry 46:3553-3565(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, ACETYLATION AT MET-1,AND MASS SPECTROMETRY. |